Mr. Kyrwood is co-head of Davis Polk’s Finance Group. He regularly advises financial institutions and alternative credit providers on a full range of financial products, from in large-cap syndicated loans to smaller direct lending transactions. Advising on over half a trillion dollars of transactions since 2015, Mr. Kyrwood has broad exposure to the global banking market and its industry participants, including deep experience in leveraged and investment-grade acquisition financings, bridge financings, LBOs, cross-border financings, restructurings and recapitalizations.

Mr. Kyrwood has represented lenders in connection with some of the largest and most complex investment grade acquisition financings over the last few years, including the over $38 billion financing for AbbVie’s acquisition of Abbott, $33.5 billion financing for Bristol-Myers’ acquisition Celgene and Cigna’s $26.7 billion financing for its acquisition of Express Scripts, among many others. He also represented Comcast in its £22 billion financing for its acquisition of Sky.

He also represents financial institutions in LBO financings across from some of the world’s largest and most sophisticated financial sponsors. Recent transaction include the $8.05 billion financing for KKR’s acquisition of Envision Health Care, $4.025 billion financing of Brand Energy & Infrastructure Services’ (a CD&R portfolio company) acquisition of Safway Group, the $4.5 billion financing for CC Capital’s acquisition of the Dun & Bradstreet Corporation and the $3.35 billion financing for Brookfield’s acquisition of Genesee & Wyoming. He also represents lenders in leveraged corporate transactions, including the $4.15 billion financing for the acquisition by United Natural Foods of Supervalu, Inc.

Mr. Kyrwood is recognized in Chamber Global and Chambers USA as a leading lawyer, and has received numerous honors, including being named “Transatlantic Dealmaker of the Year” (2016) and “Dealmaker of the Year” (2014) by The American Lawyer, “Rising Star" by New York Law Journal (2015) and Law360 (2011) and one of The M&A Advisor’s “40 Under 40” (2012). He is also a regular speaker and author on leveraged finance matters.